Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal) - Drugs in Development, 2021

October 2021 | 295 pages | ID: AB11DBF8E52DEN
Global Markets Direct

Abstracts

Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal) - Drugs in Development, 2021

SUMMARY

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ankylosing Spondylitis - Drugs In Development, 2021, provides an overview of the Ankylosing Spondylitis (Musculoskeletal Disorders) pipeline landscape.Ankylosing spondylitis is a type of arthritis that affects the spine. Ankylosing spondylitis symptoms include pain and stiffness from the neck down to the lower back. The spine's bones (vertebrae) may grow or fuse together, resulting in a rigid spine. These changes may be mild or severe, and may lead to a stooped-over posture.

REPORT HIGHLIGHTS

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Ankylosing Spondylitis - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Ankylosing Spondylitis (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Ankylosing Spondylitis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 8, 12, 7, 12, 1, 20 and 10 respectively.

Ankylosing Spondylitis (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

SCOPE

• The pipeline guide provides a snapshot of the global therapeutic landscape of Ankylosing Spondylitis (Musculoskeletal Disorders).
• The pipeline guide reviews pipeline therapeutics for Ankylosing Spondylitis (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Ankylosing Spondylitis (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Ankylosing Spondylitis (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Ankylosing Spondylitis (Musculoskeletal Disorders)

REASONS TO BUY

• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Ankylosing Spondylitis (Musculoskeletal Disorders).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Ankylosing Spondylitis (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Contents

Introduction
Ankylosing Spondylitis - Overview
Ankylosing Spondylitis - Therapeutics Development
Ankylosing Spondylitis - Therapeutics Assessment
Ankylosing Spondylitis - Companies Involved in Therapeutics Development
Ankylosing Spondylitis - Drug Profiles
Ankylosing Spondylitis - Dormant Projects
Ankylosing Spondylitis - Discontinued Products
Ankylosing Spondylitis - Product Development Milestones
Appendix

List Of Tables

LIST OF TABLES

Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by 3SBio Inc, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by AbbVie Inc, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Affibody AB, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Akeso Inc, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Alvotech ehf, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Amgen Inc, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Annji Pharmaceutical Co Ltd, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Avesthagen Ltd, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Beijing Eastern Biotech Co Ltd, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Beijing Shenzhou Cell Biotechnology Group Co Ltd, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Bio-Thera Solutions Ltd, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Biocad, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Biocon Ltd, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by BioXpress Therapeutics SA, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Boehringer Ingelheim International GmbH, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Bristol-Myers Squibb Co, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Clover Biopharmaceuticals, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by DNX Biopharmaceuticals Inc, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Dyadic International Inc, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Eli Lilly and Co, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Enzene Biosciences Ltd, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by FunPep Co Ltd, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Genor BioPharma Co Ltd, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Huabo Biopharm (Shanghai) Co Ltd, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Zhejiang Yatai Pharmaceutical Co Ltd, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects, 2021
Ankylosing Spondylitis (Bekhterev's Disease) - Discontinued Products, 2021

List Of Figures

LIST OF FIGURES

Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), 2021
Number of Products under Development by Companies, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021